Fordham again; PatLit poll

Yesterday the IPKat posted the good news that IPKat readers who were first-timers at this year's Fordham Conference were entitled to a 25% discount on the registration fee. The Kat has now discovered that what the organisers meant to say was that this discount applies to anyone who has not yet registered this year, whether they have registered for previous events or not. If you've the time and the opportunity, please take the plunge and register: you'll never regret it!
If you want the discount, please apply by email to Alice Wong. Do not attempt to register online.


Meanwhile, the PatLit weblog is running an opinion poll, which you can find in its side bar. The question is this: "Given the current state of play in the pharmaceutical sector, where would you invest your pension fund?" The poll gives three options. The poll finishes in six days' time, so please be sure to vote if you can.
Fordham again; PatLit poll Fordham again; PatLit poll Reviewed by Jeremy on Tuesday, March 24, 2009 Rating: 5

No comments:

All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.

It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.

Learn more here: http://ipkitten.blogspot.com/p/want-to-complain.html

Powered by Blogger.